Merial is a world-leading animal healthcare company with a global total market share of more than 14 percent.
An innovation-driven leader, Merial makes significant investments in research and development, with eight research and development centers around the world. Merial is committed to developing pharmaceuticals and vaccines with the highest level of quality, safety and efficacy through an extensive network of 16 manufacturing sites and eight R&D centers globally.
Merial provides a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. We play a pioneering role with governments around the globe to contain and manage various animal diseases—recognizing that the prevention and cure of animal diseases are in the interests of protecting the health of animals and of man.
Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs approximately 5,700 people and operates in more than 150 countries worldwide. Its 2009 sales were over $2.6 billion. Merial is the Animal Health subsidiary of sanofi-aventis.
For more information, please see www.merial.com.